Safety and feasibility of the use of a bevacizumab-methylcellulose mixture as an adjunct to glaucoma surgery: a pilot study

Safety and feasibility of the use of a bevacizumab-methylcellulose mixture as an adjunct to glaucoma surgery: a pilot study

ABSTRACT Bevacizumab, a monoclonal anti-vascular endothelial growth factor antibody, has been suggested as a potential healing therapeutic following glaucoma surgery. Here, we aimed to improve the bioavailability of bevacizumab when used as an adjunct therapy to non-penetrating deep sclerectomy (DS)...

Full description

Bibliographic Details
Main Authors: Jayter Silva Paula, Danilo José Lopes Secches, Marcelo Jordão Lopes Silva, Maria de Lourdes Veronese Rodrigues, Armando da Silva Cunha Junior
Format: Article
Language:English
Published: Conselho Brasileiro de Oftalmologia 2015-06-01
Series:Arquivos Brasileiros de Oftalmologia
Subjects:
Trabeculectomia/efeitos adversos
Glaucoma/cirurgia
Esclerostomia
Anticorpos monoclonais humanizados/uso terapêutico
Metilcelulose/uso terapêutico
Mitomicina/uso terapêutico
Quimioterapia adjuvante
Pressão intraocular/fisiologia
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000300015&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492015000300015&lng=en&tlng=en

Similar Items